A7409
Seroalbúmina bovina solution
35% in 0.85% sodium chloride, aseptically filled
Sinónimos:
Albúmina solution from bovine serum, Disolución BSA
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Acerca de este artículo
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleServicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Seroalbúmina bovina solution, 35% in 0.85% sodium chloride, aseptically filled
biological source
bovine
description
contains no preservative
sterility
aseptically filled
form
solution
purified by
heat shock fractionation
origin
USA origin
concentration
33.0-37.4% protein (biuret)
35% in 0.85% sodium chloride
technique(s)
microbiological culture: suitable
UniProt accession no.
storage temp.
2-8°C
Quality Level
Gene Information
bovine ... ALB(280717)
¿Está buscando productos similares? Visita Guía de comparación de productos
Categorías relacionadas
Application
Bovine Serum Albumin solution has been used:
- to block protein-coated well plates in enzyme-linked immunosorbent assay (ELISA) for immunoreactivity and cross-reactivity studies in the production of monoclonal antibodies (mAbs)
- to prepare primary antibody solution for peroxidases staining
- as a supplement for in vitro cultivation of Borrelia strains
Biochem/physiol Actions
Bovine serum albumin (BSA) serves as a protein supplement for cell culture media. BSA acts as a transport carrier for drugs, and it is commonly used to study the protein-drug interactions. Furthermore, it is known for its ability to interact with several aromatic and hydrophobic molecules of the bloodstream.
General description
Albumin belongs to the four-member albumin superfamily. It is a major protein in the circulating blood. Albumin has a helical structure with three domains that form a heart-like shape.
Clase de almacenamiento
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Sabrina Hepner et al.
Ticks and tick-borne diseases, 10(5), 1157-1161 (2019-06-27)
Borrelia turcica is a reptile-associated Borrelia species that is vectored by the hard tick Hyalomma aegyptium. Tortoises of the genus Testudo represent the principal host of adult H. aegyptium, while immature stages are less host-specific and can be found on
Chengjin Ye et al.
Microbiology spectrum, 10(6), e0273222-e0273222 (2022-11-08)
Reporter-expressing recombinant virus represents an excellent option and a powerful tool to investigate, among others, viral infection, pathogenicity, and transmission, as well as to identify therapeutic compounds that inhibit viral infection and prophylactic vaccines. To combat the ongoing coronavirus disease
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
Fatai S Oladunni et al.
Journal of virological methods, 290, 114084-114084 (2021-01-30)
The use of monoclonal neutralizing antibodies (mNAbs) is being actively pursued as a viable intervention for the treatment of Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) infection and associated coronavirus disease 2019 (COVID-19). While highly potent mNAbs have great therapeutic potential
Laura Burbaum et al.
Nature communications, 12(1), 4086-4086 (2021-07-04)
Sarcomeres, the basic contractile units of striated muscle, produce the forces driving muscular contraction through cross-bridge interactions between actin-containing thin filaments and myosin II-based thick filaments. Until now, direct visualization of the molecular architecture underlying sarcomere contractility has remained elusive.
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
Fatai S Oladunni et al.
Journal of virological methods, 290, 114084-114084 (2021-01-30)
The use of monoclonal neutralizing antibodies (mNAbs) is being actively pursued as a viable intervention for the treatment of Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) infection and associated coronavirus disease 2019 (COVID-19). While highly potent mNAbs have great therapeutic potential
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico